Suzanne joined the Global AMR R&D Hub in the Autumn of 2019, working to shape the Hub’s approach to incentives. Previously, she was a freelance researcher and analyst contributing ̶ among other things ̶ to the EU’s Innovative Medicine Initiative DRIVE-AB project, the German Government’s 2015 GUARD report and the London School of Economics’ 2009 landmark study on antimicrobial resistance incentives in support of the EU’s Swedish presidency.
Prior to specialising in pharmaceutical innovation and market failures, she was the first Head of Research at the Access to Medicine Foundation.
Suzanne began her career working for the pharmaceutical industry before spending some time managing humanitarian response projects in conflict settings. She holds degrees in pharmacology and health economics and is currently working towards her doctoral thesis.